Clinical trial

Iloprost in Preventing Lung Cancer in Former Smokers

NCT02237183

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-05

PhasePHASE1

Study timeline

Study start (actual)2015-11-05Date precision: day

Registry last updated2023-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Carcinomaunresolved

Interventions

IloprostDRUG · verified · RxNorm: iloprost

Placebo AdministrationOTHER

Quality-of-Life AssessmentOTHER

Questionnaire AdministrationOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

AuroraColorado, United States1 DenverColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02237183 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.